Drug Profile
p16 gene therapy
Latest Information Update: 20 Jul 2006
Price :
$50
*
At a glance
- Originator Nonindustrial sources
- Class Antineoplastics; Gene therapies
- Mechanism of Action Cyclin-dependent kinase 4 inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Cancer